Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329414 · ClinicalTrials.gov registry record

Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

A clinical trial of Multiple Sclerosis and Major Depressive Disorder, sponsored by University of Utah.

Recruiting
Registry status
12
Enrollment target
1
Study location

NCT06329414: Recruiting study of Multiple Sclerosis and Major Depressive Disorder, sponsored by University of Utah.

NCT06329414 is a study of Multiple Sclerosis and Major Depressive Disorder that is actively recruiting participants, run by University of Utah. The registered enrollment target is 12 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329414, a study of Multiple Sclerosis and Major Depressive Disorder, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.

Conditions Studied

Multiple Sclerosis Major Depressive Disorder Treatment-Resistant Depression

Study Locations (1)

Utah

  • University of Utah Health - Salt Lake City

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-01-16
Est. Completion 2026-01
University of Utah

818 total trials

What NCT06329414 shows while recruiting

NCT06329414 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT06329414 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06329414 about?

NCT06329414 is a clinical study titled "Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis". The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated quest...

What is the current status of trial NCT06329414?

This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2024-01-16. Estimated completion is 2026-01.

What conditions does trial NCT06329414 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Major Depressive Disorder, Treatment-Resistant Depression.

Who is sponsoring clinical trial NCT06329414?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06329414 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06329414's enrollment target sits among peer trials

12 297th of 315 higher than 15 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06329414

Source: ClinicalTrials.gov NCT06329414, the US trial registry maintained by the National Library of Medicine. NCT06329414 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.